Skip to search formSkip to main contentSkip to account menu

recombinant antihemophilic factor VIII

Known as: recombinant factor viii, rfviii 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The adsorption, structural alteration and biological activity of a recombinant Factor VIII was investigated in the presence of… 
2007
2007
Summary.  Coagulation factor VIII (FVIII) is an important glycoprotein co‐factor involved in haemostasis, functioning to… 
Review
2006
Review
2006
Summary.  The development of inhibitors in previously untreated patients (PUPs) with haemophilia A is correlated with a variety… 
Review
2004
Review
2004
Summary.  This review will focus on new technologies in development that promise to lead to further advances in haemophilia… 
2004
2004
Summary.  Clinical trials to date have not been adequately powered to assess comparatively infrequent events such as inhibitor… 
2001
2001
Large potency discrepancies between the chromogenic and one‐stage clotting methods have been reported for patients' plasma… 
Highly Cited
1998
Highly Cited
1998
To assess the risks associated with the use of central venous ports in children with haemophilia, 15 HIV‐negative patients were… 
Highly Cited
1997
Highly Cited
1997
Summary In this open multicenter study the safety and efficacy of recombinant factor VIII (rFVIII) was assessed in 39 previously… 
1990
1990
The use of factor VIII prepared genetically engineered cell lines (rFVIII) may avoid some of the problems inherently associated…